Chile
· Delayed Price · Currency is CLP Oxiquim Statistics
Total Valuation
Oxiquim has a market cap or net worth of CLP 286.20 billion. The enterprise value is 329.01 billion.
| Market Cap | 286.20B |
| Enterprise Value | 329.01B |
Important Dates
The next estimated earnings date is Wednesday, November 26, 2025.
| Earnings Date | Nov 26, 2025 |
| Ex-Dividend Date | Jul 28, 2025 |
Share Statistics
Oxiquim has 24.89 million shares outstanding. The number of shares has increased by 0.01% in one year.
| Current Share Class | 24.89M |
| Shares Outstanding | 24.89M |
| Shares Change (YoY) | +0.01% |
| Shares Change (QoQ) | +0.02% |
| Owned by Insiders (%) | 0.75% |
| Owned by Institutions (%) | n/a |
| Float | 1.45M |
Valuation Ratios
The trailing PE ratio is 11.00.
| PE Ratio | 11.00 |
| Forward PE | n/a |
| PS Ratio | 1.16 |
| PB Ratio | 2.45 |
| P/TBV Ratio | 2.45 |
| P/FCF Ratio | 16.85 |
| P/OCF Ratio | 9.06 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 7.83, with an EV/FCF ratio of 19.37.
| EV / Earnings | 12.64 |
| EV / Sales | 1.33 |
| EV / EBITDA | 7.83 |
| EV / EBIT | 10.23 |
| EV / FCF | 19.37 |
Financial Position
The company has a current ratio of 1.20, with a Debt / Equity ratio of 0.52.
| Current Ratio | 1.20 |
| Quick Ratio | 0.75 |
| Debt / Equity | 0.52 |
| Debt / EBITDA | 1.45 |
| Debt / FCF | 3.59 |
| Interest Coverage | 12.81 |
Financial Efficiency
Return on equity (ROE) is 22.70% and return on invested capital (ROIC) is 11.64%.
| Return on Equity (ROE) | 22.70% |
| Return on Assets (ROA) | 8.61% |
| Return on Invested Capital (ROIC) | 11.64% |
| Return on Capital Employed (ROCE) | 18.17% |
| Revenue Per Employee | 597.18M |
| Profits Per Employee | 63.01M |
| Employee Count | 430 |
| Asset Turnover | 1.06 |
| Inventory Turnover | 7.17 |
Taxes
In the past 12 months, Oxiquim has paid 9.23 billion in taxes.
| Income Tax | 9.23B |
| Effective Tax Rate | 26.17% |
Stock Price Statistics
The stock price has increased by +43.21% in the last 52 weeks. The beta is 0.10, so Oxiquim's price volatility has been lower than the market average.
| Beta (5Y) | 0.10 |
| 52-Week Price Change | +43.21% |
| 50-Day Moving Average | 11,228.82 |
| 200-Day Moving Average | 9,554.61 |
| Relative Strength Index (RSI) | 98.84 |
| Average Volume (20 Days) | 37 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Oxiquim had revenue of CLP 246.63 billion and earned 26.02 billion in profits. Earnings per share was 1,045.60.
| Revenue | 246.63B |
| Gross Profit | 79.13B |
| Operating Income | 32.17B |
| Pretax Income | 35.25B |
| Net Income | 26.02B |
| EBITDA | 41.40B |
| EBIT | 32.17B |
| Earnings Per Share (EPS) | 1,045.60 |
Balance Sheet
The company has 18.25 billion in cash and 61.07 billion in debt, giving a net cash position of -42.81 billion or -1,720.30 per share.
| Cash & Cash Equivalents | 18.25B |
| Total Debt | 61.07B |
| Net Cash | -42.81B |
| Net Cash Per Share | -1,720.30 |
| Equity (Book Value) | 116.96B |
| Book Value Per Share | 4,699.63 |
| Working Capital | 13.95B |
Cash Flow
In the last 12 months, operating cash flow was 31.61 billion and capital expenditures -14.62 billion, giving a free cash flow of 16.99 billion.
| Operating Cash Flow | 31.61B |
| Capital Expenditures | -14.62B |
| Free Cash Flow | 16.99B |
| FCF Per Share | 682.61 |
Margins
Gross margin is 32.09%, with operating and profit margins of 13.04% and 10.55%.
| Gross Margin | 32.09% |
| Operating Margin | 13.04% |
| Pretax Margin | 14.29% |
| Profit Margin | 10.55% |
| EBITDA Margin | 16.78% |
| EBIT Margin | 13.04% |
| FCF Margin | 6.89% |
Dividends & Yields
This stock pays an annual dividend of 704.00, which amounts to a dividend yield of 6.12%.
| Dividend Per Share | 704.00 |
| Dividend Yield | 6.12% |
| Dividend Growth (YoY) | -28.55% |
| Years of Dividend Growth | 1 |
| Payout Ratio | 41.33% |
| Buyback Yield | -0.01% |
| Shareholder Yield | 6.12% |
| Earnings Yield | 9.09% |
| FCF Yield | 5.94% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Oxiquim has an Altman Z-Score of 2.94 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.94 |
| Piotroski F-Score | 5 |